Lumenis develops and sells light- and laser-based systems for the aesthetic, surgical and ophthalmologic markets. Based on its superior technology, intellectual property and vast experience in the field, Lumenis is recognized as one of the world leaders in this expanding field. Lumenis has enjoyed substantial value appreciation since Ofer Group launched a restructuring plan in 2006.

Enzymotec develops and manufactures innovative biofunctional ingredients for dietary supplements, functional foods and infant formula. This award-winning company produces novel, lipid based ingredients for improving cognitive performance and providing balanced nutrition for babies and toddlers.

Project Better Place is a venture-backed company that aims to reduce global dependency on oil through the creation of a market-based transportation infrastructure that supports electric vehicles, providing consumers with a cleaner, sustainable, personal transportation alternative. Launched in October 2007, Project Better Place will build its first Electric Recharge Grids in Israel and Denmark and plans to deploy the infrastructure on a country-by-country basis with initial deployments beginning in 2010.

ECI Telecom (Nasdaq: ECIL) offers next generation telecommunication networks and is a leading supplier of networking infrastructure for carrier and service provider networks worldwide. Ofer Private Equity invested in 2002 and over five years implemented a restructuring programme until the successful exit in 2007.

Tecnomatix Technologies, Ltd. (NASDAQ: TCNO) is the leading provider of manufacturing process management software to the electronics, automotive, aerospace and heavy equipment industries.

Pharmos discovers and develops novel therapeutics to treat a range of symptoms with a focus on specific diseases of the nervous system, including disorders of the brain-gut axis (GI/IBS), pain/inflammation, and autoimmune disorders.